Apple has disclosed its H-1B visa salary data, offering insight into how much engineers, data scientists, designers, and ...
At Carleton University, researchers are addressing a growing demand for advanced systems that enable learners to practice ...
The company’s engineering heritage, combined with continuous investment in process automation and digital manufacturing, ...
The companies that survive will look less like pyramids and more like swarms: small, autonomous AI-first pods that move and ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
The seventh installment in a series recapping key sessions from the Data Center Frontier Trends Summit 2025 (Aug. 26–28) in ...
Contractors are shifting toward connected construction workflows—digital processes that link design, fabrication, layout, ...
Bun 1.3 revolutionizes full-stack JavaScript development with unified database APIs and zero-config frontend setup.
Potential to bring nuclear power, scalable eSAF production, and environmental-attribute monetization together into a single, integrated clean-energy platform. Exploring advancing next-generation eSAF ...